Hospira Joins Biosimilars Race With FDA Application
Hospira Inc. announced on Monday that it is asking the U.S. Food and Drug Administration to approve a copycat version of Amgen Inc.'s Epogen and Johnson & Johnson's Procrit, marking the...To view the full article, register now.
Already a subscriber? Click here to view full article